Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer

NCT03028519 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Vitamin D3

Sponsor

University of Oklahoma